Skip to main content

View full-text article in PMC

. 2020 Sep 16;11(9):e00194. doi: 10.14309/ctg.0000000000000194

Table 4.

Eradication rates according to clarithromycin resistance and group (intention-to-treat analysis)

Eradication rate in subgroups	Clarithromycin susceptible (n = 51)	Clarithromycin resistant (n = 21)	χ² test	Logistic regression analysis
Eradication rate in subgroups	Clarithromycin susceptible (n = 51)	Clarithromycin resistant (n = 21)	P Value	OR (95% CI)	P Value
Eradication rate
Total	45/51 (88.2)	14/21 (66.7)	0.031
Empirical group	24/27 (88.9)	3/9 (33.3)	0.001	Reference
Tailored group	21/24 (87.5)	11/12 (91.7)	0.773	7.111 (0.805–62.786)	0.078

Eradication rate in subgroups	Triple therapy (n = 56)	Quadruple therapy (n = 10)	χ² test	Logistic regression analysis
Eradication rate in subgroups	Triple therapy (n = 56)	Quadruple therapy (n = 10)	P Value	OR (95% CI)	P Value
Eradication rate
Total	47/56 (83.9)	10/10 (100)	<0.001
Clarithromycin susceptible	43/47 (91.5)	NA	NA	Reference
Clarithromycin resistant	4/9 (44.4)	10/10 (100)	<0.001	0.124 (0.022–0.713)	0.019

CI, confidence interval; OR, odss ratio; NA, not applicable.